| D a y L o g | |||||||||
| Friday | 16. júla 2004 | ||||||||
| Act. No. | Activity | nb | Began | Ended | Length | prescribed | Bonus / Deficit | ||
| ideal | less | least | |||||||
| I | SL | F | -4.75 | 7 | 11.75 | 7 | 6 | 5.5 | -4.75 |
| II | EX | 9.75 | 10.75 | 1 | 0.75 | -0.25 | |||
| III | MCh | 47 | 7 | 13.25 | 4 | 1.25 | -2.75 | ||
| II–III | M | 5 | 2 | -3 | |||||
| IV | FL | 12.5 | 12.75 | 0.25 | 0.25 | ok | |||
| V | PrM | 12.75 | 13 | 0.25 | 0.25 | ok | |||
| VI | QU | 13.25 | 13.75 | 0.5 | 0.5 | ok | |||
| IV–VI | US | 1 | 1 | ok | |||||
| VII | S1 | 13.75 | 14 | 0.25 | 4 | 2.75 | 2 | -3.75 | |
| VIII | S2a | 1 | |||||||
| IX | FP | 9 | 9.75 | 0.75 | 2.5 | 4 | -0.75 | ||
| X | FA | 2.5 | 4 | ||||||
| XI | F | 2.5 | 4 | ||||||
| XII | NCh | 2 | ms | ||||||
| XIII | PrN | 0.25 | ms | ||||||
| XIV | NP | 0.75 | ms | ||||||
| XII–XIV | N | 3 | NA | ||||||
| XV | S2b | 3 | 2.75 | 2 | ms | ||||
| XVI | S3 | 1.5 | 3 | ||||||
| VII | S1 | 0.25 | 4 | 2.75 | 2 | -3.75 | |||
| VIII + XV | S2 | 4 | 2.75 | 2 | -4 | ||||
| XVI | S3 | 1.5 | 3 | ||||||
| VII+VIII+XV | PS | 0.25 | 8 | 5.5 | 4 | -7.75 | |||
| VII+VIII+XV+XVI | RS | 0.25 | 8 | 5.5 | 4 | -7.75 | |||
| IX–XI | FS | 0.75 | 2.5 | 4 | -0.75 | ||||
| S | 2 | 9.5 | 7 | 5.5 | -7.5 | ||||
| XVIIa | ECh1 | 19.25 | 24.5 | 5.25 | 5 it. | -4 | |||
| XVIIb | ECh2 | na | ms | ||||||
| XVIIc | TXT | na | ok | ||||||
| XVIId | PRG | na | ms | ||||||
| XVII | ECh | 5.25 | 1.5 | -3.75 | |||||
| XVIIIa | EML1 | 49 | 14 | 19.25 | 5.25 | na | ok | ||
| XVIIIb | EML2 | na | |||||||
| XIX | AL | 1.25 | 2.25 | 2.75 | |||||
| XVIII–XIX | Out | 5.25 | 1.25 | 2.25 | 2.75 | -4 | |||
| XX | JR | 0.25 | ms | ||||||
| XXI | PrB | ms | |||||||
| I + XIV | SLS | 11.75 | 7.75 | 6.75 | 6.25 | -4 | |||
| I | SL | 24.5 | 7 | 6 | 5.5 | ||||
| 9 | 10.75 | 12.5 | 13 | MCh | 4 | ok | |||
| mixed with FP, total Loss of Concentration due to last few Days' Exhaustion… | -9 | -1 | -1 | ||||||